- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02318355
Proving Hemodilution in a Human Model for Class I Hemorrhage
April 19, 2022 updated by: Wake Forest University Health Sciences
Resuscitative Effect of Two Liters of Crystalloid on Hemodilution and Base Deficit in Healthy Volunteer Blood Donors With Class I Hemorrhage.
This study is a randomized control trial in volunteer blood donors to quantify the effect of blood loss and subsequent crystalloid infusion on hemoglobin and markers of resuscitation such as base deficit and lactate.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Blood donors were randomized to one of three arms after donation of 500cc of blood.
The control group received no intravenous fluids, while donors in the two intervention arms wither received two liters normal saline or lactated ringers.
Chemistries and blood gases were obtained before donation, after donation and after resuscitation.
Donors hemoglobin levels were then compared over time and between study arms.
Additionally, lactate and base deficit, which are markers of shock, will be collected at the time points as well to measure their response to resuscitation.
Standard statistical tests were used to compare the laboratory values between groups.
Study Type
Interventional
Enrollment (Actual)
165
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- blood bank inclusion criteria for donation
- able to donate 500cc blood
- age > or = 18
Exclusion Criteria:
- unable to obtain IV access
- multiple blood draws fail to run on laboratory assays
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Control group that receives no intravenous fluid after blood donation
|
|
|
Experimental: Lactated Ringers
Experimental group that receives two liters lactated ringers after blood donation.
|
Crystalloid intravenous solution
Other Names:
|
|
Experimental: Normal Saline
Experimental group that receives two liters normal saline after blood donation.
|
Crystalloid intravenous solution
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin (g/dL)
Time Frame: 2 hours
|
obtain hemoglobin immediately before and after donation, and after resuscitation with intravenous fluids.
From donation to end of resuscitation, the time frame will be 2 hours or less.
Donors will not be followed after the third blood draw and will be discharged from the study.
No follow-up was obtained.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lactate (mmol/L)
Time Frame: 2 hours
|
Obtain lactate immediately before and after donation, and after resuscitation with intravenous fluids.
Lactate is a measure of aneorbic metabolism and increases with worsening shock and hypoperfusion as seen in hemorrhage.
From donation to end of resuscitation, the time frame will be 2 hours or less.
Donors will not be followed after the third blood draw and will be discharged from the study.
No follow-up was obtained.
|
2 hours
|
|
Base deficit (mmol/L)
Time Frame: 2 hours
|
Obtain base deficit immediately before and after donation, and after resuscitation with intravenous fluids.
Base deficit is a measure of unmeasured acid in the blood, indicating acidosis and shock, and increases in worsening hypoperfusion.
From donation to end of resuscitation, the time frame will be 2 hours or less.
Donors will not be followed after the third blood draw and will be discharged from the study.
No follow-up was obtained.
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ronald F Sing, DO, Professor of Surgery
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ross SW, Christmas AB, Fischer PE, Holway H, Seymour R, Huntington CR, Heniford BT, Sing RF. Defining Dogma: Quantifying Crystalloid Hemodilution in a Prospective Randomized Control Trial with Blood Donation as a Model for Hemorrhage. J Am Coll Surg. 2018 Sep;227(3):321-331. doi: 10.1016/j.jamcollsurg.2018.05.005. Epub 2018 Jun 4.
- Ross SW, Christmas AB, Fischer PE, Holway H, Walters AL, Seymour R, Gibbs MA, Heniford BT, Sing RF. Impact of common crystalloid solutions on resuscitation markers following Class I hemorrhage: A randomized control trial. J Trauma Acute Care Surg. 2015 Nov;79(5):732-40. doi: 10.1097/TA.0000000000000833.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
December 10, 2014
First Submitted That Met QC Criteria
December 12, 2014
First Posted (Estimate)
December 17, 2014
Study Record Updates
Last Update Posted (Actual)
April 21, 2022
Last Update Submitted That Met QC Criteria
April 19, 2022
Last Verified
December 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-08-19E
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds and Injuries
-
Solventum US LLC3MWithdrawn
-
Centre Hospitalier Universitaire de NīmesCompletedWounds and Injuries, Hands | Wounds and Injuries, Wrists | Wounds and Injuries, Feet | Wounds and Injuries, AnklesFrance
-
Baskent UniversityNot yet recruitingOccupational Exposure | Needlestick Injuries | Sharps Injuries
-
National Center for Gastroentestinal and Liver...CompletedNeedlestick Injuries
-
Superior UniversityActive, not recruitingNeedle Stick InjuriesPakistan
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruitingWounds and Injuries / MortalityChina
-
Assaf-Harofeh Medical CenterUnknownInjuries and Wounds
-
Hospital Universiti Sains MalaysiaActive, not recruiting
Clinical Trials on lactated ringers
-
Ascension Genesys HospitalCompletedInduction of Labor Affected Fetus / NewbornUnited States
-
Spectrum Health HospitalsDeltex Medical, Inc.CompletedRectal Cancer | Crohn's Disease | Ulcerative Colitis | Diverticulitis | Colon Cancer | Colon Polyps | Rectal PolypsUnited States
-
Aestique Medical CenterCompletedOsteo Arthritis KneeUnited States
-
Lawson Health Research InstituteCompleted
-
Zhongnan HospitalUnknownSeptic Shock | Intensive Care Unit | Fluid Resuscitation | Crystalloid SolutionChina
-
London Health Sciences Centre Research Institute...CompletedDiabetic KetoacidosisCanada
-
Changhai HospitalFirst People's Hospital of Hangzhou; LanZhou University; Peking Union Medical... and other collaboratorsCompletedPancreatitis, Chronic | Pancreatic Duct StoneChina
-
Northwestern UniversityTerminatedPregnancy | Labor PainUnited States
-
Mayo ClinicRecruitingLower Urinary Tract Obstructive Syndrome | Renal Failure Congenital | Congenital Renal Anomaly Nos | Renal Agenesis and DysgenesisUnited States
-
Thomas Jefferson UniversityUnknownPancreaticoduodenectomyUnited States